Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP)
Abstract
Summary: Background Hyperinsulinaemia has been suggested as an important factor for developing hypokalaemic paralysis in patients with thyrotoxic periodic paralysis (TPP). Since hyperinsulinaemia is a common feature of insulin resistance, there may be a causal relationship between insulin resistance and TPP. Objective To compare insulin sensitivity between subjects with a history of TPP and others with a history of thyrotoxicosis without periodic paralysis. Methods Insulin sensitivity measured by euglycaemic hyperinsulinaemic clamp and 75‐g oral glucose tolerance test (OGTT) were performed nonselectively in 10 subjects with a history of TPP (TPP group) and 10 age‐ and sex‐matched subjects with a history of simple thyrotoxicosis (control group). All participants had euthyroidism and fasting plasma glucose of < 5·55 mmol/l at the time of the study. Results Body mass index and waist circumference of the TPP group were higher than that of the control group. One of 10 (10%) subjects in the TPP group and 6 of 10 (60%) in the control group had BMI of < 23 kg/m 2. Areas under the curve (AUC) of plasma glucose after OGTT were comparable, while the AUC of serum insulin of the TPP group was higher than in the control group. The TPP group had lower insulin sensitivity than the control group. Conclusion The subjects with a history of TPP were more obese and had lower insulin sensitivity than those with a history of simple thyrotoxicosis. Insulin resistance with compensatory hyperinsulinaemia may be a key feature of the pathogenesis of TPP.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Insulin participates in the pathogenesis of hypokalemia in TPP.
“Hyperinsulinemia is also observed in acute attack of TPP, and the release of insulin in response to oral glucose challenge is exaggerated in TPP patients, supporting the idea that insulin participates in the pathogenesis of hypokalemia in TPP [9].”
From Thyrotoxic Periodic Paralysis: Clinical Challenges (2014) · cites this paper as [9]
Hyperinsulinemia is observed in acute attack of TPP, and the release of insulin in response to oral glucose challenge is exaggerated in TPP patients.
“Hyperinsulinemia is also observed in acute attack of TPP, and the release of insulin in response to oral glucose challenge is exaggerated in TPP patients, supporting the idea that insulin participates in the pathogenesis of hypokalemia in TPP [9].”
From Thyrotoxic Periodic Paralysis: Clinical Challenges (2014) · cites this paper as [9]
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · see citing works
Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.
Goodpaster, B. H., Kelley, D. E., Wing, R. R., Meier, A., & Thaete, F. L. (1999) · Diabetes · doi:10.2337/diabetes.48.4.839 · Cited by 608 · see citing works
Periodic paralysis complicating thyrotoxicosis in Chinese.
McFadzean, A. J., & Yeung, R. (1967) · BMJ · doi:10.1136/bmj.1.5538.451 · Cited by 303 · see citing works
Regulation of the Na, K-pump in skeletal muscle
Clausen, T., & Everts, M. E. (1989) · Kidney International · doi:10.1038/ki.1989.1 · Cited by 237 · see citing works
Kelley, D. E. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2597 · Cited by 227 · see citing works
Effect of experimental potassium deficiency on glucose and insulin metabolism
Rowe, J. W., Tobin, J. D., Rosa, R. M., & Andres, R. (1980) · Metabolism · doi:10.1016/0026-0495(80)90074-8 · Cited by 226 · see citing works
Insulin Sensitivity Among Obese Children and Adolescents, According to Degree of Weight Loss
Reinehr, T., Kiess, W., Kapellen, T., & Andler, W. (2004) · Pediatrics · doi:10.1542/peds.2003-0649-f · Cited by 211 · see citing works
THE ASSOCIATION OF PERIODIC PARALYSIS AND HYPERTHYROIDISM IN JAPAN
OKINAKA, S., SHIZUME, K., UNO, S., WATANABE, A., IRIE, M., NOGUCHI, A., KUMA, S., KUMA, K., & ITO, T. (1957) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-17-12-1454 · Cited by 206 · see citing works
In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis.
Chan, A., Shinde, R., Chow, C. C., Cockram, C. S., & Swaminathan, R. (1991) · BMJ · doi:10.1136/bmj.303.6810.1096 · Cited by 160 · see citing works
Thyrotoxic Periodic Paralysis: Report of 10 Cases and Review of Electromyographic Findings
Kelley, D. E. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390110139031 · Cited by 158 · see citing works
Lin, S.-H., & Lin, Y.-F. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.22090 · Cited by 148 · see citing works
Dias Da Silva, M. R., Cerutti, J. M., Arnaldi, L. A. T., & Maciel, R. M. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020698 · Cited by 113 · see citing works
Kung, A. W. C., Lau, K. S., Fong, G. C. Y., & Chan, V. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030924 · Cited by 77 · see citing works
Chan, A., Shinde, R., Chow, C. C., Cockram, C. S., & Swaminathan, R. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02532.x · Cited by 77 · see citing works
Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis
Lee, K. O., Taylor, E. A., Oh, V. M. S., Cheah, J. S., & Aw, S. E. (1991) · The Lancet · doi:10.1016/0140-6736(91)91710-c · Cited by 69 · see citing works
Franssila-Kallunki, A., Rissanen, A., Ekstrand, A., Ollus, A., & Groop, P. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.2.356 · Cited by 62 · see citing works
Absence of Ion Channels CACN1AS and SCN4A Mutations in Thyrotoxic Hypokalemic Periodic Paralysis
Ng, W. Y., Lui, K. F., Thai, A. C., & Cheah, J. S. (2004) · Thyroid · doi:10.1089/105072504773297858 · Cited by 57 · see citing works
Shishiba, Y., Shimizu, T., Saito, T., & Shizume, K. (1972) · Metabolism · doi:10.1016/0026-0495(72)90071-6 · Cited by 56 · see citing works
Lacey, R. J., Berrow, N. S., London, N. J. M., et al. (1990) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0050049 · Cited by 39 · see citing works
Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone
Liu, Z., Braverman, L. E., & Malabanan, A. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.427 · Cited by 38 · see citing works
Thyrotoxic Periodic Paralysis Induced by Pulse Methylprednisolone
Wongraoprasert, S., Buranasupkajorn, P., Sridama, V., & Snabboon, T. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0044 · Cited by 37 · see citing works
Thyrotoxic periodic paralysis and polymorphisms of sodium–potassium ATPase genes
Kung, A. W. C., Lau, K. S., Cheung, W. M. W., & Chan, V. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02442.x · Cited by 31 · see citing works
Thyrotoxic Periodic Paralysis Associated with a Mutation in the Sodium Channel Gene SCN4A
Lane, A., Markarian, K., & Braziunene, I. (2004) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2004.17.12.1679 · Cited by 27 · see citing works
Tang, N. L. S., Chow, C. C., Ko, G. T. C., Tai, M. H. L., Kwok, R., Yao, X., & Cockram, C. S. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02079.x · Cited by 26 · see citing works
Brown, J. D., Kangwanprasert, M., Tice, A. D., & Melish, J. S. (2007) · PubMed · Cited by 15 · see citing works
Jongjaroenprasert, W., Chanprasertyotin, S., Butadej, S., Nakasatien, S., Charatcharoenwitthaya, N., Himathongkam, T., & Ongphiphadhanakul, B. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03083.x · Cited by 13 · see citing works
Inhibition of sulphonylurea-stimulated insulin secretion by beta adrenergic blockade
SIREK, O. V., Sirek, A., & Policova, Z. (1975) · Diabetologia · doi:10.1007/bf00422390 · Cited by 12 · see citing works
Donovan, L., Parkins, V. M., & Mahalingham, A. (2007) · Thyroid · doi:10.1089/thy.2006.0288 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Thyrotoxic Periodic Paralysis: Clinical Challenges
Vijayakumar, A., Ashwath, G., & Thimmappa, D. (2014) · Journal of Thyroid Research · doi:10.1155/2014/649502 · Cited by 88 · see citing works
“Hyperinsulinemia is also observed in acute attack of TPP, and the release of insulin in response to oral glucose challenge is exaggerated in TPP patients, supporting the idea that insulin participates in the pathogenesis of hypokalemia in TPP [9].”
RetractedNovel etiopathophysiological aspects of thyrotoxic periodic paralysis
Maciel, R. M. B., Lindsey, S. C., & Dias da Silva, M. R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.58 · Cited by 86 · see citing works
Analytic review: thyrotoxic periodic paralysis: a review
Pothiwala, P., & Levine, S. N. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066609358849 · Cited by 80 · see citing works
Thyrotoxic periodic paralysis: clinical and molecular aspects
Falhammar, H., Thorén, M., & Calissendorff, J. (2012) · Endocrine · doi:10.1007/s12020-012-9777-x · Cited by 74 · see citing works
Thyrotoxic periodic paralysis: a case study and review of the literature
Meseeha, M., Parsamehr, B., Kissell, K., & Attia, M. (2017) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2017.1316906 · Cited by 32 · see citing works
- Authors
- Soonthornpun, S., Setasuban, W., & Thamprasit, A.
- Affiliations
- Prince of Songkla University (TH)
- Corresponding author
- Soonthornpun, Supamai
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2009-03-31
- Volume
- 70
- Issue
- 5
- Pages
- 794-797
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2133917516
- Cited by
- 47
- References
- 28
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2018: 4 · 2017: 2 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 6
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Thailand Research Fund
- Prince of Songkla University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Potassium and Related Disorders
- Keywords
- thyrotoxic periodic paralysis, insulin resistance, insulin sensitivity, hyperinsulinemia, thyrotoxicosis, hypokalaemic paralysis, obesity, body mass index, waist circumference, hyperinsulinemic-euglycemic clamp, oral glucose tolerance test
- MeSH terms
- Sodium-Potassium-Exchanging ATPase, Adult, Blood Glucose, Glucose Tolerance Test, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Male, Middle Aged, Obesity, Thyrotoxicosis, Glucose Clamp Technique, Body Mass Index, Case-Control Studies, Hypokalemic Periodic Paralysis, Waist Circumference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review